PhRMA International Affairs Transition: Ritter To Succeed Herzfeld As Head
This article was originally published in The Pink Sheet Daily
Shannon Herzfeld will leave the association at the end of the year. Assistant General Counsel Geralyn Ritter is promoted to VP-international affairs and will work with Herzfeld during the transition period.
You may also be interested in...
Darragh brings experience with international intellectual property issues from PhRMA to new post at BIO. He will report to outgoing BIO President Feldbaum, and answer to BIO’s Food & Ag membership.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.